Close Menu

Scientists at Orion Genomics and other labs, including Cold Spring Harbor, have used microarrays in a genome-wide screen to look for epigenetic biomarkers for early stage detection of breast cancer. In the study, published yesterday in PLoS ONE, they found about 200 loci that were differentially methylated, and then went on to validate these in 230 clinical samples.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.